US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.345
  • +0.495+10.21%
Trading Nov 25 14:54 ET
452.53MMarket Cap-2172P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.173M--
--2024/Q4-- / 4.238M--
--2024/Q36.865M / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
--2024/Q15.695M / 2.250M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.173M--
--2024/Q4-- / 4.238M--
--2024/Q36.865M / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
--2024/Q15.695M / 2.250M--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

  • Verve Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 07:31 ET

  • Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

    Nov 5 07:16 ET

  • Verve Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:34 ET

  • Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

    Aug 8 07:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data